Literature DB >> 15647480

Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia.

Takanori Hashimoto1, Sarah E Bergen, Quyen L Nguyen, Baoji Xu, Lisa M Monteggia, Joseph N Pierri, Zhuoxin Sun, Allan R Sampson, David A Lewis.   

Abstract

Dysfunction of inhibitory neurons in the prefrontal cortex (PFC), represented by decreased expression of GABA-related genes such as the 67 kDa isoform of glutamate decarboxylase (GAD67) and parvalbumin (PV), appears to contribute to cognitive deficits in subjects with schizophrenia. We investigated the involvement of signaling mediated by brain-derived neurotrophic factor (BDNF) and its receptor tyrosine kinase TrkB in producing the altered GABA-related gene expression in schizophrenia. In 15 pairs of subjects with schizophrenia and matched control subjects, both BDNF and TrkB mRNA levels, as assessed by in situ hybridization, were significantly decreased in the PFC of the subjects with schizophrenia, whereas the levels of mRNA encoding the receptor tyrosine kinase for neurotrophin-3, TrkC, were unchanged. In this cohort, within-pair changes in TrkB mRNA levels were significantly correlated with those in both GAD67 and PV mRNA levels. Decreased BDNF, TrkB, and GAD67 mRNA levels were replicated in a second cohort of 12 subject pairs. In the combined cohorts, the correlation between within-pair changes in TrkB and GAD67 mRNA levels was significantly stronger than the correlation between the changes in BDNF and GAD67 mRNA levels. Neither BDNF nor TrkB mRNA levels were changed in the PFC of monkeys after a long-term exposure to haloperidol. Genetically introduced decreases in TrkB expression, but not in BDNF expression, also resulted in decreased GAD67 and PV mRNA levels in the PFC of adult mice; in addition, the cellular pattern of altered GAD67 mRNA expression paralleled that present in schizophrenia. Decreased TrkB signaling appears to underlie the dysfunction of inhibitory neurons in the PFC of subjects with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647480      PMCID: PMC6725470          DOI: 10.1523/JNEUROSCI.4035-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  76 in total

1.  Isodirectional tuning of adjacent interneurons and pyramidal cells during working memory: evidence for microcolumnar organization in PFC.

Authors:  S G Rao; G V Williams; P S Goldman-Rakic
Journal:  J Neurophysiol       Date:  1999-04       Impact factor: 2.714

2.  Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia.

Authors:  L A Glantz; D A Lewis
Journal:  Arch Gen Psychiatry       Date:  2000-01

3.  Expression of brain-derived neurotrophic factor, neurotrophin-3 and their receptor messenger RNAs in monkey rhinal cortex.

Authors:  T Hashimoto; H Okuno; W Tokuyama; Y X Li; Y Miyashita
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

4.  Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory.

Authors:  S G Rao; G V Williams; P S Goldman-Rakic
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

5.  Destabilization of cortical dendrites and spines by BDNF.

Authors:  H W Horch; A Krüttgen; S D Portbury; L C Katz
Journal:  Neuron       Date:  1999-06       Impact factor: 17.173

6.  BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex.

Authors:  Z J Huang; A Kirkwood; T Pizzorusso; V Porciatti; B Morales; M F Bear; L Maffei; S Tonegawa
Journal:  Cell       Date:  1999-09-17       Impact factor: 41.582

7.  Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects.

Authors:  J N Pierri; A S Chaudry; T U Woo; D A Lewis
Journal:  Am J Psychiatry       Date:  1999-11       Impact factor: 18.112

8.  Quantitative evaluation of neurotrophin and trk mRNA expression in visual and limbic areas along the occipito-temporo-hippocampal pathway in adult macaque monkeys.

Authors:  H Okuno; W Tokuyama; Y X Li; T Hashimoto; Y Miyashita
Journal:  J Comp Neurol       Date:  1999-06-07       Impact factor: 3.215

9.  Expression of TrkB and TrkC but not BDNF mRNA in neurochemically identified interneurons in rat visual cortex in vivo and in organotypic cultures.

Authors:  T Gorba; P Wahle
Journal:  Eur J Neurosci       Date:  1999-04       Impact factor: 3.386

10.  Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression.

Authors:  T Ohnuma; S J Augood; H Arai; P J McKenna; P C Emson
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

View more
  146 in total

1.  Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features.

Authors:  Allison A Curley; Dominique Arion; David W Volk; Josephine K Asafu-Adjei; Allan R Sampson; Kenneth N Fish; David A Lewis
Journal:  Am J Psychiatry       Date:  2011-06-01       Impact factor: 18.112

Review 2.  Brain-derived neurotrophic factor and neuropsychiatric disorders.

Authors:  Anita E Autry; Lisa M Monteggia
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

3.  Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice.

Authors:  Francesco Matrisciano; Patricia Tueting; Stefania Maccari; Ferdinando Nicoletti; Alessandro Guidotti
Journal:  Neuropsychopharmacology       Date:  2011-11-16       Impact factor: 7.853

4.  Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia.

Authors:  Monica Beneyto; Andrew Abbott; Takanori Hashimoto; David A Lewis
Journal:  Cereb Cortex       Date:  2010-09-15       Impact factor: 5.357

5.  Enhanced brain-derived neurotrophic factor signaling in the nucleus accumbens of juvenile rats.

Authors:  Melissa L Perreault; Theresa Fan; Brian F O'Dowd; Susan R George
Journal:  Dev Neurosci       Date:  2013-09-07       Impact factor: 2.984

6.  Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.

Authors:  Kazuko Sakata; Abigail E Overacre
Journal:  J Neurochem       Date:  2017-08-16       Impact factor: 5.372

Review 7.  BDNF-TrkB signaling and neuroprotection in schizophrenia.

Authors:  Chirayu D Pandya; Ammar Kutiyanawalla; Anilkumar Pillai
Journal:  Asian J Psychiatr       Date:  2012-11-03

Review 8.  Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; Harvey M Morris
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

9.  Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia.

Authors:  Dibyadeep Datta; Dominique Arion; Kaitlyn M Roman; David W Volk; David A Lewis
Journal:  Am J Psychiatry       Date:  2016-08-13       Impact factor: 18.112

10.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.

Authors:  T Hashimoto; D Arion; T Unger; J G Maldonado-Avilés; H M Morris; D W Volk; K Mirnics; D A Lewis
Journal:  Mol Psychiatry       Date:  2007-05-01       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.